Inflammasome Therapeutics announced it raised $3.8 Million in an amended filing from an offering of $3.8 Million
Jan 26, 2024•almost 2 years ago
Amount Raised
$3.8 Million
Round Type
seed
NewtonHealthcare
Company Information
Company
Inflammasome Therapeutics
Location
57 CHAPEL ST.
Newton, Massachusetts, United States
About
Inflammasome Therapeutics is a science based company founded to develop therapies for prevalent, degenerative diseases such as Alzheimer’s disease, multiple sclerosis, macular degeneration, and Parkinson's disease.